0000899243-17-011717.txt : 20170503 0000899243-17-011717.hdr.sgml : 20170503 20170503193844 ACCESSION NUMBER: 0000899243-17-011717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170501 FILED AS OF DATE: 20170503 DATE AS OF CHANGE: 20170503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 167 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6176795500 MAIL ADDRESS: STREET 1: 167 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZEIN YOUSSEF EL CENTRAL INDEX KEY: 0001193366 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 17811300 MAIL ADDRESS: STREET 1: HYBRIDON INC STREET 2: 345 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals II, L.P. CENTRAL INDEX KEY: 0001562069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 17811301 BUSINESS ADDRESS: STREET 1: STARCO CENTER BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT 2020-3313 STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 9611363362 MAIL ADDRESS: STREET 1: STARCO CENTER BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT 2020-3313 STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals I LP CENTRAL INDEX KEY: 0001534425 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 17811302 BUSINESS ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 0119611363362 MAIL ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Invest Corp CENTRAL INDEX KEY: 0001534428 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 17811303 BUSINESS ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 0119611363362 MAIL ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-01 0 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001534428 Pillar Invest Corp C/O IDERA PHARMACEUTICALS, INC. 167 SIDNEY STREET CAMBRIDGE MA 02139 1 0 1 0 0001534425 Pillar Pharmaceuticals I LP PILLAR INVEST OFFSHORE SAL, STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 1 0 1 0 0001562069 Pillar Pharmaceuticals II, L.P. PILLAR INVEST OFFSHORE SAL, STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 1 0 1 0 0001193366 ZEIN YOUSSEF EL PILLAR INVEST OFFSHORE SAL, STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 1 0 1 0 Common Stock 2017-05-01 4 S 0 41578 2.2591 D 0 I See footnotes Common Stock 2017-05-01 4 S 0 409237 2.2591 D 0 I See footnotes Common Stock 2017-05-01 4 X 0 409237 0.00 A 0 I See footnotes Warrants 0.70 2017-05-01 4 X 0 409237 0.00 D 2012-11-09 2017-11-09 Common Stock 409237 4624824 I See footnotes The sales reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Persons. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $2.25-$2.355. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"), of which Pillar Invest Corporation ("Pillar GP") is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. As of the date hereof, Pillar I owns directly 2,090,125 shares of common stock of the Issuer. Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"), of which Pillar GP is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. As of the date hereof, Pillar II owns directly 6,135,132 shares of common stock of the Issuer. Youssef El Zein is a director and controlling stockholder of Pillar GP and serves as the representative of a Pillar I, Pillar II and Pillar GP on the Issuer's board of directors. Mr. El Zein disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and Pillar II and this report shall not be deemed an admission that he is the beneficial owners of any such securities, except to the extent of his pecuniary interest therein, if any, by virtue of his ownership interest in Pillar GP. As of the date hereof, Mr. El Zein owns directly 528,538 shares of common stock of the Issuer. Warrants beneficially owned and exercised for shares of common stock by Pillar II. Pillar GP disclaims Section 16 beneficial ownership of the Warrants and the common stock underlying such warrants and this report shall not be deemed an admission that Pillar GP is the beneficial owner of any such securities, except to the extent of its pecuniary interest therein. Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person 2017-05-03 /s/ Youssef El Zein 2017-05-03